Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-14-063858

Options or other derivatives

  • Chief Operating Officer acquired 50,671 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McBride John S. Chief Operating Officer 2014-10-15 Grant or award · Stock Option (right to buy) +50,671 50,671 D
Loading xslF345X03/doc4.xml…